latest blog entries
Loading...
Branding...
latest headlines for company on cafepharma
Pharmalot
Mon, 04/29/13 - 11:40 am
tags: Biogen Idec, drug launches, MS, multiple sclerosis, Tecfidera
Pharmalot
Thu, 04/25/13 - 10:56 am
tags: Biogen Idec, Fumaderm, multiple sclerosis, PML, psoriasis, Tecfidera
Investors.com
Tue, 04/23/13 - 11:34 am
tags: Amgen, Biogen Idec, Celgene, earnings, Gilead, Medicines Company
Motley Fool
Mon, 04/22/13 - 11:14 am
TheStreet.com
Tue, 04/02/13 - 10:58 am
tags: AbbVie, Achillion, Aegerion, Amarin, Arena Pharmaceuticals, AstraZeneca, Aveo Pharmaceutical, Biogen Idec, Bristol-Myers Squibb, Delcath, Dendreon, Depomed, Gilead, GSK, Merck, NewLink Genetics, Raptor Pharmaceuticals, Rigel, Sangamo BioSciences, Sucampo, Titan Pharmaceuticals, Valeant Pharmaceuticals, Vertex Pharmaceuticals, Vivus, Zogenix
Seeking Alpha
Tue, 04/02/13 - 9:48 am
tags: Biogen Idec, MS, multiple sclerosis, Novartis, Sanofi, Tecfidera
TheStreet.com
Thu, 03/28/13 - 8:45 am
tags: BG-12, Biogen Idec, FDA, MS, multiple sclerosis, Tecfidera
Investors.com
Fri, 03/22/13 - 11:45 am
Last 30 twitter posts
-
Biogen Idec nombra Director Científico a Spyros Artavanis-Tsakonas - t.co/2auSalFGWt
-
Biogen Idec nombra Director Científico a Spyros Artavanis-Tsakonas - t.co/bNADd6nF5X
-
Biogen Idec nombra Director Científico a Spyros Artavanis-Tsakonas - t.co/RGW2jYY3My
-
Biogen Idec taps Harvard professor as new CSO t.co/kne3rAFVWj
-
Making the Most out of Existing Biopharma Plant Capacity - Biogen Idec took a flexible approach, using an underuti... t.co/8RI3ouwlbS
-
Biogen Idec taps Harvard professor as new CSO t.co/D18Hz8xAcs via @BostonBizNews
-
Multiple Sclerosis Alerts - Google: Biogen Idec taps Harvard professor as new CSO: Earlier this week, Biogen s... t.co/0gXBlQhze8
-
RT @msconnections: Biogen Idec Submits Application To FDA For Approval Of Plegridy™ (Peginterferon Beta-1a) In Multiple Sclerosis - t.co/d4jei3AJEb
-
Biogen Idec Submits Application To FDA For Approval Of Plegridy™ (Peginterferon Beta-1a) In Multiple Sclerosis - t.co/d4jei3AJEb
-
RT @BiotechGuide: Biogen Idec taps Harvard professor as new CSO t.co/dnC2CcO2Io
-
Biogen Idec presenta solicitud aprobación Plegridy t.co/ibseXv2bjo t.co/rXl9SMj2ch
-
Biogen Idec nombra Director Científico a Spyros Artavanis-Tsakonas - t.co/Hao1LeFKxR
-
Biogen Idec Appoints Spyros Artavanis-Tsakonas Chief Scientific Officer t.co/zP9NlmMjy1
-
RT @BiotechGuide: Biogen Idec names chief scientific officer t.co/lGYCDyFZx1
-
RT @PharmaNewsDaily: Pharma News: Biogen Idec seeks FDA approval for Plegridy in multiple sclerosis therapy t.co/8sh0Mpa0oa
-
"Biogen Idec Submits Application To FDA For Approval Of Plegridy™ (Peginterferon Beta-1a) In Multiple Sclerosis" t.co/rasmQVuIjZ #MS
-
MediemexPharma blog: Biogen Idec nombra director científico a Spyros Artavanis-Tsakonas t.co/MRENvIKPQt
-
RT @emfundazioa: Biogen Idec presenta solicitud ante la FDA para aprobación de PLEGRIDY para #esclerosismultiple t.co/YVSkqnu3da
-
Understanding Good Logistical Practices by Karen Arnold of Biogen Idec #ColdChain presentaion please RT - t.co/pQ0M5RlYNf
-
RT @emfundazioa: Biogen Idec presenta solicitud ante la FDA para aprobación de PLEGRIDY para #esclerosismultiple t.co/YVSkqnu3da
-
Biogen Idec names chief scientific officer t.co/lGYCDyFZx1
-
Pharmaceutical News: Biogen Idec appoints permanent chief scientific officer t.co/nKx3WmCfZA
-
Biogen Idec: Spyros Artavanis-Tsakonas nommé conseiller scientifique en chef t.co/YfIjfBo9Ia
-
RT @thegarithos: Biogen Idec Inc. said Friday it will price Tecfidera, its newly approved pill to treat multiple sclerosis, at $54,900 a year per patient ..
-
[Herald Business] Biogen Idec names chief scientific officer t.co/JpTyos6BHN
-
Biogen Idec nombra Director Científico a Spyros Artavanis-Tsakonas - t.co/6HP2MSowtk
-
[Boston Biz Jrnl] Biogen Idec taps Harvard professor as new CSO t.co/qBEqob41vE
-
[Boston Biz Jrnl] Biogen Idec taps Harvard professor as new CSO t.co/lpFAi6H9Hl
-
Biogen Idec seeks FDA approval for Plegridy in multiple sclerosis therapy: Biogen Idec is seeking FDA approval... t.co/sfaMvMz5rs
-
Biogen Idec nombra Director Científico a Spyros Artavanis-Tsakonas t.co/CQcN9AnWkn vía @la_informacion
Latest Health Message Board Posts
... marketed as a DMD only for those who do not respond to CRABs. Here is an article from the Boston Globe. zhttp://bostonglobe.com/business/2013/01/16/biogen-idec-seeks-regulatory-for-wider-use-multiple-sclerosis-drug/PJaSuvS0G55jr0nUTlFmIP/story.html
Posted by:
Lulu54
at
2013-05-21 05:00:00
on
medhelp.org
... It's important that you can work with him/her. Janes advice about contacting Biogen Idec, the makers of Avonex. They can be very helpful when it comes to getting things paid for. I'm a Tysabri usre, also from Bigen Idec, and they are a good resource. Kyle
Posted by:
Lulu54
at
2013-03-28 05:00:00
on
medhelp.org
First is some good news for Avonex and Rebif users. It looks like Biogen-Idec is going to be seeking marketing approval for monthly dosing later this year. http://www.medpagetoday.com/Neurology/MultipleSclerosis/36993?utm_source=share&utm_medium= ...
Posted by:
TLC_31
at
2013-03-19 05:00:00
on
medhelp.org
Biogen Idec's much anticipated new oral MS drug has finally received a name - it is no longer BG-12 but Tecfidera. The 'birth' is still expected the end of March and there is great anticipation it will be a heavyweight in the MS drug arsenal. Stay tuned -
Posted by:
Ojibajo
at
2013-03-14 22:33:28
on
medhelp.org
... com/2013/02/2...-killing-us/6/ A spokesman at Genentech for the Biogen Idec�Genentech partnership would not say what the drug cost the companies to make, but according to its latest annual report, Biogen Idec�s cost of sales � the incremental expense ...
Posted by:
Ihurt
at
2013-03-03 22:37:00
on
chronsforum.com
... com/2013/02/2...-killing-us/6/ A spokesman at Genentech for the Biogen Idec�Genentech partnership would not say what the drug cost the companies to make, but according to its latest annual report, Biogen Idec�s cost of sales � the incremental expense ...
Posted by:
JohnnyO
at
2013-03-03 22:21:00
on
chronsforum.com
Contact Biogen Idec (or your nurse from there that trained you to inject) they have an assistance program. I think that there is another a few other ones but I ...
Posted by:
Lulu54
at
2013-02-10 06:00:00
on
medhelp.org
... FDA ruling late next week. http://www.biogenidec.com/PRESS_RELEASE_DETAILS.aspx?ID=5981&ReqId=1798029 http://www.bloomberg.com/news/2013-03-19/biogen-idec-gets-new-u-s-patent-for-multiple-sclerosis-drug.html
Posted by:
kwarendorf
at
2013-01-25 06:00:00
on
medhelp.org
And yes, Biogen Idec obviously had their ducks in a row. Considering they had hoped to have this approved last year and it was delayed until now - I imagine they had lots going on in the background.
Posted by:
kwarendorf
at
2013-01-18 06:00:00
on
medhelp.org
... and the patient repsonse, this subcutaneous shot will be given every two or four weeks. Read more at http://www.dailyfinance.com/2013/05/21/biogen-idec-submits-application-to-fda-for-approva/ It's nice to have options .... Laura
Posted by:
kwarendorf
at
2013-01-17 06:00:00
on
medhelp.org